Skip to main content

Bacterial Infections of the Small and Large Intestine

  • Chapter
  • First Online:
Textbook of Pediatric Gastroenterology, Hepatology and Nutrition

Abstract

Diarrhea caused by enteric infections is a major cause of morbidity and mortality worldwide. This chapter highlights the mechanisms of diarrhea associated with bacterial agents. Several bacterial pathogens can cause secretory diarrhea such as Vibrio cholerae and enterotoxigenic Escherichia coli. Other bacteria induce inflammatory diarrhea such as Clostridium difficile, Shigella, and selected strains of pathogenic E. coli, while some induce osmotic diarrhea by causing extensive enterocyte damage by cytopathic mechanisms, such as enteroaggregative E. coli. The underlying mechanisms of infectious diarrhea include alterations in ion transport as well as cytotoxic effects. These are induced by bacterial cells and/or by their virulence factors. Diarrheal mechanisms may be indirectly caused by inflammation or by altered regulatory processes involving hormones and neurotransmitters. This chapter also provides a review of the current treatment of acute infectious diarrhea by bacterial agents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Guarino A, Wudy A, Basile F, Ruberto E, Buccigrossi V. Composition and roles of intestinal microbiota in children. J Matern Fetal Neonatal Med. 2012;25:63–6.

    Article  PubMed  Google Scholar 

  2. Kunzelmann K, Mall M. Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev. 2002;82:245–89.

    Article  CAS  PubMed  Google Scholar 

  3. Zachos NC, Tse M, Donowitz M. Molecular physiology of intestinal Na+/H+ exchange. Annu Rev Physiol. 2005;67:411–43.

    Article  CAS  PubMed  Google Scholar 

  4. Barrett KE, Keely SJ. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu Rev Physiol. 2000;62:535–72.

    Article  CAS  PubMed  Google Scholar 

  5. Kopic S, Geibel JP. Toxin mediated diarrhea in the 21 century: the pathophysiology of intestinal ion transport in the course of ETEC, V. cholerae and rotavirus infection. Toxins (Basel) 2010;2:2132–57.

    Article  CAS  Google Scholar 

  6. Golin-Bisello F, Bradbury N, Ameen N. STa and cGMP stimulate CFTR translocation to the surface of villus enterocytes in rat jejunum and is regulated by protein kinase G. Am J Physiol Cell Physiol. 2005;289:C708–16.

    Article  CAS  PubMed  Google Scholar 

  7. Viswanathan VK, Hodges K, Hecht G. Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea. Nat Rev Microbiol. 2009;7:110–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. 2013;70:631–59.

    Article  CAS  PubMed  Google Scholar 

  9. Schwan C, Stecher B, Tzivelekidis T, van Ham M, Rohde M, Hardt W-D, Wehland J, Aktories K. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog. 2009;5:e1000626.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Zhang Q, Li Q, Wang C, Li N, Li J. Redistribution of tight junction proteins during EPEC infection in vivo. Inflammation 2012;35:23–32.

    Article  PubMed  Google Scholar 

  11. Bruzzese E, Lo Vecchio A, Guarino A. Hospital management of children with acute gastroenteritis. Curr Opin Gastroenterol. 2013;29:23–30.

    Article  PubMed  Google Scholar 

  12. Pieścik-Lech M, Shamir R, Guarino A, Szajewska H. Review article: the management of acute gastroenteritis in children. Aliment Pharmacol Ther. 2013;37:289–303.

    Article  PubMed  Google Scholar 

  13. Vanden Broeck D, Horvath C, De Wolf MJS. Vibrio cholerae: cholera toxin. Int J Biochem Cell Biol. 2007;39:1771–5.

    Article  CAS  PubMed  Google Scholar 

  14. Subramanya SB, Rajendran VM, Srinivasan P, Nanda Kumar NS, Ramakrishna BS, Binder HJ. Differential regulation of cholera toxin-inhibited Na–H exchange isoforms by butyrate in rat ileum. Am J Physiol Gastrointest Liver Physiol. 2007;293:G857–63.

    Article  CAS  PubMed  Google Scholar 

  15. Hodges K, Gill R. Infectious diarrhea: cellular and molecular mechanisms. Gut Microbes. 2010;1:4–21.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Farmakiotis D, Varughese J, Sue P, Andrews P, Brimmage M, Dobroszycki J, Coyle CM. Typhoid fever in an inner city hospital: a 5-year retrospective review. J Travel Med. 2013;20:17–21.

    Article  PubMed  Google Scholar 

  17. Pach A, Tabbusam G, Khan MI, Suhag Z, Hussain I, Hussain E, Mumtaz U, Haq IU, Tahir R, Mirani A, Yousafzai A, Sahastrabuddhe S, Ochiai RL, Soofi S, Clemens JD, Favorov MO, Bhutta ZA. Formative research and development of an evidence-based communication strategy: the introduction of Vi typhoid fever vaccine among school-aged children in Karachi, Pakistan. J Health Commun. 2013;18:306–24.

    Article  PubMed  Google Scholar 

  18. Centers for Disease Control and Prevention. Surveillance for foodborne disease outbreaks—United States, 2009–2010. Morb Mortal Wkly Rep. 2013;62:41–7.

    Google Scholar 

  19. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34:346–53.

    Article  PubMed  Google Scholar 

  20. Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, Gopinath S, Naidu N, Choudhury B, Weimer BC, Monack DM, Sonnenburg JL. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013;502:96–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Peniche AG, Savidge TC, Dann SM. Recent insights into Clostridium difficile pathogenesis. Curr Opin Infect Dis. 2013;26:447–53.

    CAS  PubMed  Google Scholar 

  22. Knight CL, Surawicz CM. Clostridium difficile infection. Med Clin North Am. 2013;97:523–36, ix.

    Article  PubMed  Google Scholar 

  23. Perelle S, Gibert M, Bourlioux P, Corthier G, Popoff MR. Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun. 1997;65:1402–7.

    PubMed Central  CAS  PubMed  Google Scholar 

  24. Kasendra M, Barrile R, Leuzzi R, Soriani M. Clostridium difficile toxins facilitate bacterial colonization by modulating the fence and gate function of colonic epithelium. J Infect Dis. 2014;209(7):1095–104.

    Article  CAS  PubMed  Google Scholar 

  25. Li S, Shi L, Yang Z, Feng H. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol. Pathog Dis. 2013;67:11–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev. 2005;18:247–63.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Fasano A. Toxins and the gut: role in human disease. Gut 2002;50(Suppl 3):III9–14.

    Google Scholar 

  28. Shen A. Clostridium difficile toxins: mediators of inflammation. J Innate Immun. 2012;4:149–58.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Lo Vecchio A, Zacur GM. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol. 2012;28:1–9.

    Article  PubMed  Google Scholar 

  30. Lo Vecchio A, Giannattasio A, Duggan C, De Masi S, Ortisi MT, Parola L, Guarino A. Evaluation of the quality of guidelines for acute gastroenteritis in children with the AGREE instrument. J Pediatr Gastroenterol Nutr. 2011;52:183–9.

    Article  PubMed  Google Scholar 

  31. Pascarella F, Martinelli M, Miele E, Del Pezzo M, Roscetto E, Staiano A. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr. 2009;154:854–8.

    Article  PubMed  Google Scholar 

  32. Azad MB, Konya T, Maughan H, Guttman DS, Field CJ, Chari RS, Sears MR, Becker AB, Scott JA, Kozyrskyj AL. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ. 2013;185:385–94.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Rousseau C, Poilane I, De Pontual L, Maherault A-C, Le Monnier A, Collignon A. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis. 2012;55:1209–15.

    Article  PubMed  Google Scholar 

  34. Khanna S, Baddour LM, Huskins WC, Kammer PP, Faubion WA, Zinsmeister AR, Harmsen WS, Pardi DS. The epidemiology of Clostridium difficile infection in children: a population-based study. Clin Infect Dis. 2013;56:1401–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53:994–1002.

    Article  PubMed  Google Scholar 

  36. Brandt LJ. American Journal of Gastroenterology Lecture: intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol. 2013;108:177–85.

    Article  PubMed  Google Scholar 

  37. Centers for Disease Control and Prevention. Preliminary FoodNet Data on the incidence of infection with pathogens transmitted commonly through food—10 States, 2008. Morb Mortal Wkly Rep. 2009;58:333–7.

    Google Scholar 

  38. Ashida H, Ogawa M, Mimuro H, Kobayashi T, Sanada T, Sasakawa C. Shigella are versatile mucosal pathogens that circumvent the host innate immune system. Curr Opin Immunol. 2011;23:448–55.

    Article  CAS  PubMed  Google Scholar 

  39. Kasper CA, Sorg I, Schmutz C, Tschon T, Wischnewski H, Kim ML, Arrieumerlou C. Cell-cell propagation of NF-κB transcription factor and MAP kinase activation amplifies innate immunity against bacterial infection. Immunity 2010;33:804–16.

    Article  CAS  PubMed  Google Scholar 

  40. Guttman JA, Finlay BB. Tight junctions as targets of infectious agents. Biochim Biophys Acta. 2009;1788:832–41.

    Article  CAS  PubMed  Google Scholar 

  41. Al-Hasani K, Henderson IR, Sakellaris H, Rajakumar K, Grant T, Nataro JP, Robins-Browne R, Adler B. The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation. Infect Immun. 2000;68:2457–63.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Andrzejewska M, Szczepańska B, Klawe JJ, Spica D, Chudzińska M. Prevalence of Campylobacter jejuni and Campylobacter coli species in cats and dogs from Bydgoszcz (Poland) region. Pol J Vet Sci. 2013;16:115–20.

    CAS  PubMed  Google Scholar 

  43. Bahrndorff S, Rangstrup-Christensen L, Nordentoft S, Hald B. Foodborne disease prevention and broiler chickens with reduced Campylobacter infection. Emerg Infect Dis. 2013;19:425–30.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Gharst G, Oyarzabal OA, Hussain SK. Review of current methodologies to isolate and identify Campylobacter spp. from foods. J Microbiol Methods. 2013;95:84–92.

    Article  CAS  PubMed  Google Scholar 

  45. Metchock B, Lonsway DR, Carter GP, Lee LA, McGowan JE. Yersinia enterocolitica: a frequent seasonal stool isolate from children at an urban hospital in the southeast United States. J Clin Microbiol. 1991;29:2868–9.

    PubMed Central  CAS  PubMed  Google Scholar 

  46. Zheng H, Sun Y, Lin S, Mao Z, Jiang B. Yersinia enterocolitica infection in diarrheal patients. Eur J Clin Microbiol Infect Dis. 2008;27:741–52.

    Article  CAS  PubMed  Google Scholar 

  47. Rosner BM, Werber D, Höhle M, Stark K. Clinical aspects and self-reported symptoms of sequelae of Yersinia enterocolitica infections in a population-based study, Germany 2009–2010. BMC Infect Dis. 2013;13:236.

    Article  PubMed Central  PubMed  Google Scholar 

  48. Ebringer R, Colthorpe D, Burden G, Hindley C, Ebringer A. Yersinia enterocolitica biotype I. Diarrhoea and episodes of HLA B27 related ocular and rheumatic inflammatory disease in South-East England. Scand J Rheumatol. 1982;11:171–6.

    Article  CAS  PubMed  Google Scholar 

  49. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2:123–40.

    Article  CAS  PubMed  Google Scholar 

  50. Weiglmeier PR, Rösch P, Berkner H. Cure and curse: E. coli heat-stable enterotoxin and its receptor guanylyl cyclase C. Toxins (Basel). 2010;2:2213–29.

    Article  CAS  Google Scholar 

  51. Sato T, Shimonishi Y. Structural features of Escherichia coli heat-stable enterotoxin that activates membrane-associated guanylyl cyclase. J Pept Res. 2004;63:200–6.

    Article  CAS  PubMed  Google Scholar 

  52. Albano F, De Marco G, Berni Canani R, Cirillo P, Buccigrossi V, Giannella R, Guarino A. Guanylin and E. coli heat-stable enterotoxin induce chloride secretion through direct interaction with basolateral compartment of rat and human colonic cells. Pediatr Res. 2005;58:159–63.

    Article  CAS  PubMed  Google Scholar 

  53. Buccigrossi V, Armellino C, Ruberto E, Barone MV, Marco GDE, Esposito C, Guarino A. Polar effects on ion transport and cell proliferation induced by GC-C ligands in intestinal epithelial cells. Pediatr Res. 2011;69:17–22.

    Article  CAS  PubMed  Google Scholar 

  54. Phillips AD, Giròn J, Hicks S, Dougan G, Frankel G. Intimin from enteropathogenic Escherichia coli mediates remodelling of the eukaryotic cell surface. Microbiology 2000;146(Pt 6):1333–44.

    Article  CAS  PubMed  Google Scholar 

  55. Martínez C, Lobo B, Pigrau M, Ramos L, González-Castro AM, Alonso C, Guilarte M, Guilá M, de Torres I, Azpiroz F, Santos J, Vicario M. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut 2013;62:1160–8.

    Article  PubMed  Google Scholar 

  56. Turner JR. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol. 2006;169:1901–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  57. Turck D, Bernet J-P, Marx J, Kempf H, Giard P, Walbaum O, Lacombe A, Rembert F, Toursel F, Bernasconi P, Gottrand F, McFarland L V, Bloch K. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr. 2003;37:22–6.

    Article  CAS  PubMed  Google Scholar 

  58. Vidal JE, Canizález-Román A, Gutiérrez-Jiménez J, Navarro-García F. Molecular pathogenesis, epidemiology and diagnosis of enteropathogenic Escherichia coli. Salud Publica Mex. 2007;49:376–86.

    Article  PubMed  Google Scholar 

  59. Slutsker L, Ries AA, Greene KD, Wells JG, Hutwagner L, Griffin PM. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med. 1997;126:505–13.

    Article  CAS  PubMed  Google Scholar 

  60. Ferreira AJ, Elias WP, Pelayo JS, Giraldi R, Pedroso MZ, Scaletsky IC. Culture supernatant of Shiga toxin-producing Escherichia coli strains provoke fluid accumulation in rabbit ileal loops. FEMS Immunol Med Microbiol. 1997;19:285–8.

    Article  CAS  PubMed  Google Scholar 

  61. Hauf N, Chakraborty T. Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli. J Immunol. 2003;170:2074–82.

    Article  CAS  PubMed  Google Scholar 

  62. Wittenberg DF. Management guidelines for acute infective diarrhoea/gastroenteritis in infants. S Afr Med J. 2012;102:104–7.

    CAS  PubMed  Google Scholar 

  63. Guarino A, Lo Vecchio A, Berni Canani R. Chronic diarrhoea in children. Best Pract Res Clin Gastroenterol. 2012;26:649–61.

    Article  PubMed  Google Scholar 

  64. Henry FJ, Udoy AS, Wanke CA, Aziz KM. Epidemiology of persistent diarrhea and etiologic agents in Mirzapur, Bangladesh. Acta Paediatr Suppl. 1992;381:27–31.

    Article  CAS  PubMed  Google Scholar 

  65. Maluta RP, Fairbrother JM, Stella AE, Rigobelo EC, Martinez R, Avila FA de. Potentially pathogenic Escherichia coli in healthy, pasture-raised sheep on farms and at the abattoir in Brazil. Vet Microbiol. 2013;S 0378:591–9.

    Google Scholar 

  66. Pruvost I, Dubos F, Chazard E, Hue V, Duhamel A, Martinot A. The value of body weight measurement to assess dehydration in children. PLoS One. 2013;8:e55063.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  67. Lindsay BR, Chakraborty S, Harro C, Li S, Nataro JP, Sommerfelt H, Sack DA, Stine OC. Quantitative PCR and culture evaluation for Enterotoxigenic E. coli (ETEC) associated diarrhea in volunteers. FEMS Microbiol Lett. 2014;352(1):25–31.

    Article  CAS  PubMed  Google Scholar 

  68. Valentini D, Vittucci AC, Grandin A, Tozzi AE, Russo C, Onori M, Menichella D, Bartuli A, Villani A. Coinfection in acute gastroenteritis predicts a more severe clinical course in children. Eur J Clin Microbiol Infect Dis. 2013;32:909–15.

    Article  CAS  PubMed  Google Scholar 

  69. Abba K, Sinfield R, Hart CA, Garner P. Antimicrobial drugs for persistent diarrhoea of unknown or non-specific cause in children under six in low and middle income countries: systematic review of randomized controlled trials. BMC Infect Dis. 2009;9:24.

    Article  PubMed Central  PubMed  Google Scholar 

  70. Van den Berg J, Berger MY. Guidelines on acute gastroenteritis in children: a critical appraisal of their quality and applicability in primary care. BMC Fam Pract. 2011;12:134.

    Article  PubMed Central  PubMed  Google Scholar 

  71. World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. Geneva: WHO; 2005.

    Google Scholar 

  72. Centers for Disease Control and Prevention. Notes from the field: emergence of Shigella flexneri 2a resistant to ceftriaxone and ciprofloxacin—South Carolina, October 2010. Morb Mortal Wkly Rep. 2010;59:1619.

    Google Scholar 

  73. Boumghar-Bourtchai L, Mariani-Kurkdjian P, Bingen E, Filliol I, Dhalluin A, Ifrane SA, Weill F-X, Leclercq R. Macrolide-resistant Shigella sonnei. Emerg Infect Dis. 2008;14:1297–9.

    Article  PubMed Central  PubMed  Google Scholar 

  74. Vrints M, Mairiaux E, Van Meervenne E, Collard J-M, Bertrand S. Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. J Clin Microbiol. 2009;47:1379–85.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  75. Varsano I, Eidlitz-Marcus T, Nussinovitch M, Elian I. Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children. J Pediatr. 1991;118:627–32.

    Article  CAS  PubMed  Google Scholar 

  76. Onwuezobe IA, Oshun PO, Odigwe CC. Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev. 2012;11:CD001167.

    PubMed  Google Scholar 

  77. Tahan S, Morais MB, Wehba J, Scaletsky ICA, Machado AMO, Silva LQCD, Fagundes Neto U. A randomized double-blind clinical trial of the effect of non-absorbable oral polymyxin on infants with severe infectious diarrhea. Braz J Med Biol Res. 2007;40:209–19.

    Article  CAS  PubMed  Google Scholar 

  78. Medina A, Horcajo P, Jurado S, De la Fuente R, Ruiz-Santa-Quiteria JA, Domínguez-Bernal G, Orden JA. Phenotypic and genotypic characterization of antimicrobial resistance in enterohemorrhagic Escherichia coli and atypical enteropathogenic E. coli strains from ruminants. J Vet Diagn Invest. 2011;23:91–5.

    Article  PubMed  Google Scholar 

  79. Trehan I, Shulman RJ, Ou C-N, Maleta K, Manary MJ. A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy. Am J Gastroenterol. 2009;104:2326–33.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  80. Pathela P, Zahid Hasan K, Roy E, Huq F, Kasem Siddique A, Bradley Sack R. Diarrheal illness in a cohort of children 0–2 years of age in rural Bangladesh: I. Incidence and risk factors. Acta Paediatr. 2006;95:430–7.

    Article  PubMed  Google Scholar 

  81. Nylund CM, Goudie A, Garza JM, Fairbrother G, Cohen MB. Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med. 2011;165:451–7.

    Article  PubMed Central  PubMed  Google Scholar 

  82. Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, Stollman N, Rohlke F, Surawicz C. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:1079–87.

    Article  PubMed  Google Scholar 

  83. Lo Vecchio A, Della Ventura B, Nicastro E. Clostridium difficile antibodies: a patent evaluation (WO2013028810). Expert Opin Ther Pat. 2013;23:1635–40.

    Article  CAS  PubMed  Google Scholar 

  84. Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, Nichol G, Thomas WD, Leney M, Sloan S, Hay CA, Ambrosino DM. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med. 2010;362:197–205.

    Article  CAS  PubMed  Google Scholar 

  85. Goldenberg JZ, Ma SSY, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, Guyatt GH, Johnston BC. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5:CD006095.

    PubMed  Google Scholar 

  86. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo J V, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999;135:564–8.

    Article  CAS  PubMed  Google Scholar 

  87. Pieścik-Lech M, Urbańska M, Szajewska H. Lactobacillus GG (LGG) and smectite versus LGG alone for acute gastroenteritis: a double-blind, randomized controlled trial. Eur J Pediatr. 2013;172:247–53.

    Article  PubMed Central  PubMed  Google Scholar 

  88. Lo Vecchio A, Cohen MB. Fecal microbiota transplantation for Clostridium difficile infection: benefits and barriers. Curr Opin Gastroenterol. 2014;30:47–53.

    Article  PubMed  Google Scholar 

  89. Wadhwa N, Natchu UCM, Sommerfelt H, Strand TA, Kapoor V, Saini S, Kainth US, Bhatnagar S. ORS containing zinc does not reduce duration or stool volume of acute diarrhea in hospitalized children. J Pediatr Gastroenterol Nutr. 2011;53:161–7.

    Article  CAS  PubMed  Google Scholar 

  90. Umamaheswari B, Biswal N, Adhisivam B, Parija SC, Srinivasan S. Persistent diarrhea: risk factors and outcome. Indian J Pediatr. 2010;77:885–8.

    Article  CAS  PubMed  Google Scholar 

  91. Wiegering V, Kaiser J, Tappe D, Weissbrich B, Morbach H, Girschick HJ. Gastroenteritis in childhood: a retrospective study of 650 hospitalized pediatric patients. Int J Infect Dis. 2011;15:e401–7.

    Article  PubMed  Google Scholar 

  92. World Health Organization. The treatment of diarrhoea—a manual for physicians and other senior health workers. Geneva: WHO; 2005.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vittoria Buccigrossi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Buccigrossi, V., Spagnuolo, M. (2016). Bacterial Infections of the Small and Large Intestine. In: Guandalini, S., Dhawan, A., Branski, D. (eds) Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. Springer, Cham. https://doi.org/10.1007/978-3-319-17169-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17169-2_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-17168-5

  • Online ISBN: 978-3-319-17169-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics